Article 76: Eye On: Melanoma
- CenterWatch editorial staff review new treatments in research for melanoma and identify 37 investigational drugs in clinical development for this illness.
Article 77: Bristol-Myers Squibb: A Reform Model for Partnering with CROs?
- Bristol-Myers Squibb spent a year remaking how it works with CROs; new master contracts include performance standards
Article 78: Sponsors Send Mixed Message to CROs
- CenterWatch in-depth survey of 15 sponsors finds that concerns over quality and cost may slow -- but not halt -- growth in outsourcing of clinical development services.
- Sponsors are developing diverse approaches for more effective, strategic management of CRO services.
